|
Announcements
BECKMAN COULTER, INC.
SELECTS CLINIVATION GLOBAL® XI.
Global leader in the manufacturing of biomedical testing instrument systems, tests and
supplies for automated laboratory processes selects clinivation Global xi as the foundation for managing
their global market clearance operations.
Natick,
MA, June 30, 2009 - clinivation, Inc. announced today that Beckman Coulter, Inc.
has selected the clinivation Global xi enterprise solution for Market Clearance
Management.
"Beckman Coulter is one of America's largest biomedical companies.
Beckman Coulter develops, manufactures and markets products that
simplify, automate and innovate complex biomedical tests. We are
pleased that they have selected the clinivation Global xi Market
Clearance Platform as the foundation for managing their global market
clearance operations," said Richard Morroney, R.A.C., C.Q.A., clinivation's
Vice President, Global Market Clearance Solutions.
About the clinivation Global xi
Market Clearance Platform
The clinivation Global xi enterprise
solution for Market Clearance Management enables executives and their teams to
address the challenges of execution, effective governance, and lean business performance
in their global market clearance operations. By enabling excellence in global
market clearance operations to advance the revenue intrinsic to market clearance
success, clinivation Global xi liberates revenue that's trapped-in-process.
About Beckman Coulter, Inc.
Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and
supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum-from
pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing-Beckman
Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around
the world. The company, based in Fullerton, Calif., reported 2007 annual sales of $2.76 billion with more
than 78 percent of this amount generated by recurring revenue from supplies, test kits and services.
For more information, please visit www.beckmancoulter.com.
About
clinivation, Inc. Clinivation is the leading provider
of integrated solutions that enable global market clearance. Guided by our singular
vision - "Excellence in Market Clearance" - clinivation accelerates
the entire market clearance cycle to advance new worldwide revenue and achieve
new milestones of enterprise value. Used in over 1,000,000 product registrations
by more than 100 companies worldwide, clinivation's end-to-end technology and
services deliver on our vision by eliminating revenue traps from global market
clearance operations, increasing process velocity with on-demand regulatory intelligence,
automating clearance-driven business controls, simplifying content unification
into market clearance applications, aligning quality systems with global market
clearance priorities, streamlining clinical development with clearance-focused
trials, and enabling management with key performance indicators for continuous
improvement and effective governance. The world's leading medical device,
diagnostics, hospital supply, and dental supply companies select clinivation because
of our medtech industry focus and our unique, integrated solutions that seamlessly
adapt to existing business processes and enterprise infrastructure- without the
need to write custom code.
Our core brands include the clinivation Global xi
market clearance platform, clinivation WorldView on-demand regulatory intelligence,
and clinivation Clinical Suite and clinivation Registry Suite electronic data
capture and clinical data management software. Founded in 1999, the company
is headquartered in Natick, Massachusetts, with regional offices in North America
and Asia. Visit clinivation online at www.clinivation.com For
further information: For more information on clinivation's
integrated solutions that enable global market clearance, please click
here or call us at 508.655.6560. | 
